Literature DB >> 35958467

Establishment and validation of a nomogram that predicts the risk of type 2 diabetes in obese patients with non-alcoholic fatty liver disease: a longitudinal observational study.

Xintian Cai1,2, Mengru Wang1, Shasha Liu1, Yujuan Yuan1, Junli Hu1, Qing Zhu1, Jing Hong1, Guzailinuer Tuerxun1, Huimin Ma1, Nanfang Li1.   

Abstract

OBJECTIVE: This study aimed to establish and validate a nomogram for better assessment of the risk of type 2 diabetes (T2D) in obese patients with non-alcoholic fatty liver disease (NAFLD) based on independent predictors.
METHODS: Of 1820 eligible participants from the NAGALA cohort enrolled in the study. Multivariate Cox regression was employed to construct the nomogram. The performance was assessed by area under the receiver operating characteristic curve (AUC), C-index, calibration curve, decision curve analysis, and Kaplan-Meier analysis.
RESULTS: Five predictors were selected from 17 variables. The AUC values at different time points all indicated that the model constructed with these five predictors had good predictive power. Decision curves indicated that the model could be applied to clinical applications.
CONCLUSIONS: We established and validated a reasonable, economical nomogram for predicting the risk of T2D in obese NAFLD patients. This simple clinical tool can help with risk stratification and thus contribute to the development of effective prevention programs against T2D in obese patients with NAFLD. AJTR
Copyright © 2022.

Entities:  

Keywords:  Type 2 diabetes; cohort study; nomogram; non-alcoholic fatty liver disease; obesity

Year:  2022        PMID: 35958467      PMCID: PMC9360847     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  40 in total

1.  The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.

Authors:  Takuya Fukuda; Masahide Hamaguchi; Takao Kojima; Yoshitaka Hashimoto; Akihiro Ohbora; Takahiro Kato; Naoto Nakamura; Michiaki Fukui
Journal:  Liver Int       Date:  2015-07-30       Impact factor: 5.828

Review 2.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

Review 3.  Non-alcoholic fatty liver disease - A global public health perspective.

Authors:  Zobair M Younossi
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

4.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

Review 5.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

6.  Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Int J Obes (Lond)       Date:  2018-05-01       Impact factor: 5.095

7.  Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study.

Authors:  Xin-Tian Cai; Li-Wei Ji; Sha-Sha Liu; Meng-Ru Wang; Mulalibieke Heizhati; Nan-Fang Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-11       Impact factor: 3.168

8.  A Novel Risk Score for Type 2 Diabetes Containing Sleep Duration: A 7-Year Prospective Cohort Study among Chinese Participants.

Authors:  Xiangtong Liu; Zhiwei Li; Jingbo Zhang; Shuo Chen; Lixin Tao; Yanxia Luo; Xiaolin Xu; Jason Peter Fine; Xia Li; Xiuhua Guo
Journal:  J Diabetes Res       Date:  2020-01-04       Impact factor: 4.011

9.  Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.

Authors:  Fumiaki Imamura; Amanda M Fretts; Matti Marklund; Andres V Ardisson Korat; Wei-Sin Yang; Maria Lankinen; Waqas Qureshi; Catherine Helmer; Tzu-An Chen; Jyrki K Virtanen; Kerry Wong; Julie K Bassett; Rachel Murphy; Nathan Tintle; Chaoyu Ian Yu; Ingeborg A Brouwer; Kuo-Liong Chien; Yun-Yu Chen; Alexis C Wood; Liana C Del Gobbo; Luc Djousse; Johanna M Geleijnse; Graham G Giles; Janette de Goede; Vilmundur Gudnason; William S Harris; Allison Hodge; Frank Hu; Albert Koulman; Markku Laakso; Lars Lind; Hung-Ju Lin; Barbara McKnight; Kalina Rajaobelina; Ulf Riserus; Jennifer G Robinson; Cecilia Samieri; Mackenzie Senn; David S Siscovick; Sabita S Soedamah-Muthu; Nona Sotoodehnia; Qi Sun; Michael Y Tsai; Tomi-Pekka Tuomainen; Matti Uusitupa; Lynne E Wagenknecht; Nick J Wareham; Jason H Y Wu; Renata Micha; Rozenn N Lemaitre; Dariush Mozaffarian; Nita G Forouhi
Journal:  PLoS Med       Date:  2020-06-12       Impact factor: 11.069

10.  Development and Validation of a Novel Model for Predicting the 5-Year Risk of Type 2 Diabetes in Patients with Hypertension: A Retrospective Cohort Study.

Authors:  Xintian Cai; Qing Zhu; Ting Wu; Bin Zhu; Xiayire Aierken; Ayguzal Ahmat; Nanfang Li
Journal:  Biomed Res Int       Date:  2020-09-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.